| Name | AR-M 1000390 hydrochloride |
| Description | AR-M 1000390 hydrochloride (ARM-390 HCl) , also known as ARM-390, is a low-internalizing nonpeptidic δ-selective opioid receptor agonist; derivative of SNC 80. Does not trigger acute desensitization of the analgesic response; reduces CFA-induced hyperalgesia. Brain penetrant following systemic administration. |
| In vitro | Does not trigger acute desensitization of the analgesic response |
| In vivo | Reduces CFA-induced hyperalgesia. Brain penetrant following systemic administration. |
| Storage | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.2 mM), Sonication is recommended. H2O : 38.49 mg/mL (99.99 mM), Sonication is recommended. DMSO : 38.49 mg/mL (99.99 mM), Sonication is recommended.
|
| Keywords | δ-opioid receptor | OpioidReceptor | Opioid Receptor | Inhibitor | inhibit | ARM-390 Hydrochloride | AR-M-1000390 Hydrochloride | AR-M1000390 Hydrochloride | ARM 390 Hydrochloride | AR-M 1000390 Hydrochloride | ARM 1000390 hydrochloride | AR-M 1000390 | AR M 1000390 hydrochloride |
| Inhibitors Related | Docusate sodium | Bevenopran | Mirtazapine | Matrine | (-)-Menthol | Cuminaldehyde | Progesterone | Naltrexone hydrochloride | Cebranopadol | BTRX-335140 | Bisacodyl | Mianserin hydrochloride |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Neuronal Signaling Compound Library | Membrane Protein-targeted Compound Library | Anti-Parkinson's Disease Compound Library | Neurotransmitter Receptor Compound Library | Endocrinology-Hormone Compound Library | Bioactive Compounds Library Max | Preclinical Compound Library | GPCR Compound Library | Anti-Cancer Compound Library |